5 results match your criteria: "Boston University Institute for Health System Innovation and Policy[Affiliation]"
Healthc (Amst)
December 2021
Boston Medical Center, Boston University School of Medicine, Boston University Institute for Health System Innovation and Policy, USA.
Prior to the COVID-19 pandemic, studies demonstrated an alarming prevalence of burnout in primary care. In the midst of the pandemic, primary care clinician wellbeing deteriorated and burnout rates increased, yet many organizational efforts to reduce burnout were put on hold due to the urgency of the pandemic. In this article, we present the "Reducing Burnout Driver Diagram" as a tool that clinical leaders and policy makers can use to address and mitigate primary care clinician burnout.
View Article and Find Full Text PDFFam Med
July 2021
Department of Family Medicine, Boston University School of Medicine, Boston, MA.
Fam Med
June 2021
Boston University School of Medicine, Department of Family Medicine, Boston, MA.
Background And Objectives: Scholarship is recognized as a challenge in many family medicine residency programs. Among evaluations of scholarship curricula, few describe resident experiences of such interventions. To bridge this gap in knowledge, we measured resident confidence, satisfaction, and participation before and after implementing a new scholarship curriculum.
View Article and Find Full Text PDFHealth Aff (Millwood)
March 2020
Rachel Sachs is an associate professor of law at the Washington University School of Law, in St. Louis, Missouri.
The Affordable Care Act contained a range of provisions that altered prescription drug access and affordability for patients, payers, and providers. Yet the act stopped short of instituting systemic changes in the pricing of drugs, in part to address concerns that more fundamental changes might disrupt the development of new medicines. Looking back a decade after the Affordable Care Act became law, we found that new drug approvals have accelerated and the therapeutic advances embodied in some novel medicines are substantial-as are the prices that companies are charging for them.
View Article and Find Full Text PDFLaryngoscope
September 2020
Boston University School of Medicine, Boston, Massachusetts, U.S.A.
Objective: Competing risk analysis is a powerful assessment for cancer risk factors and covariates. This method can better elucidate insurance status and other social determinants of health covariates in oral cavity cancer treatment, survival, and disparities.
Study Design: Retrospective cohort study using the Surveillance, Epidemiology, and End Results (SEER) database.